El ukwanda kwezidakamizwa zokunciphisa umzimba njenge-Ozempic namanye ama-agonists e-GLP-1 Sekwehlule kokubili amasistimu okunakekelwa kwezempilo kanye nabalawuli. Ukuntuleka kokupakishwa okusemthethweni manje kuhlanganiswe igagasi lemikhiqizo yomgunyathi, elungiselelwe ngokungafanele noma ethengiswa ngamawebhusayithi nezinkundla zokuxhumana ezizenza iziteshi ezisemthethweni.
Phakathi kwezixwayiso ezivela ngaphakathi kwemboni yezemithi uqobo, izaziso ze I-European Medicines Agency (EMA) Futhi ngamacala abhaliwe omonakalo omkhulu wezempilo, impikiswano ithuthele eBrussels, kumakhemisi omphakathi futhi, ngaphezu kwakho konke, kubathengi baseYurophu abafuna ukunciphisa umzimba ngokushesha.
I-Ozempic ne-GLP-1 agonists: ukuthi bayini nokuthi kungani kunesidingo esingaka
Ozempic, Wegovy, Mounjaro noma Zepbound kukhona izidakamizwa ezisuselwa kuma-analogues we-GLP-1 receptorLe mithi, ekuqaleni eyenzelwe ukuphatha isifo sikashukela sohlobo 2 futhi, kwezinye izimo, iphinde igunyazwe ukwelapha ukukhuluphala, isebenza ngokulawula ukudla kanye namazinga eglucose, okuholela ekulahlekelweni okukhulu kwesisindo ezigulini eziningi.
Impumelelo yemidiya yalawa mapeni ajovayo, ahlanganiswe ne imiyalezo elula mayelana “nemijovo yokulahlekelwa isisindo eyisimangaliso”Lokhu kubangele ukwanda kwesidingo emhlabeni jikelele. E-Europe, iziphathimandla zinezabelo ezilinganiselwe zokuqinisekisa ukufinyelela kwabantu abanesifo sikashukela, okuholela emakethe efanayo yemikhiqizo okuthiwa “Ozempic” kanye nemikhiqizo efanayo.
Lesi simo se Ukushoda isikhathi eside kanye nokulindela okukhulu Kuyindawo ekahle yokuzalanisa amawebhusayithi, amaphrofayili enkundla yezokuxhumana kanye nalokho okubizwa ngokuthi "imitholampilo eku-inthanethi" ethembisa izinguqulo ezishibhile, ukuthunyelwa kwe-counter noma imiphumela evezayo ngaphandle kwezilawuli zezokwelapha.
Ukukhathazeka eBrussels: izingxube emakhemisi namakhophi angagunyaziwe
Inkampani yezemithi yaseDenmark I-Novo Nordisk, ebhekele i-Ozempic ne-WegovyLe nkampani igqamise isici esibucayi sokulungiswa kabusha okukhulu kwemithetho yezemithi okuxoxiswana ngayo njengamanje e-European Union. Ngokusho kwenkampani, uhlaka olusha lungavumela amakhemisi athile ukuthi enze izinhlobo ezihlanganisiwe zale mithi yokunciphisa isisindo ngezinga elikhulu kunamanje.
Ngaphansi kwemithetho yamanje, ukulungiswa kwemithi yomuntu ngamunye emakhemisi kuvunyelwe kuphela izimo eziqondile kakhuluIzimo zokushoda, izimfuneko ezikhethekile zomthamo (isb., imithamo ephansi yezingane), noma lapho kungekho isethulo esitholakalayo sokuthengisa esifanela isiguli. UNovo Nordisk wesaba ukuthi amagama ahlongozwayo axegisa le mikhawulo.
Umkhulumeli wenkampani uxwayise ngokuthi uma amathuba okwenza imishanguzo ehlanganisiwe ene-analogue ye-GLP-1 anda, Amanye amakhemisi angase aqale "ukwenza isitokwe"Okungukuthi, ukulungiselela nokugcina lezi zingxube kusengaphambili, kunokuba uzenze kuphela ngokuphendula iresiphi ethile. Ngokubona kwabo lokho kungavula umnyango “wentshonalanga yasendle” yemikhiqizo engalawulwayo ezolingisa i-Ozempic noma i-Wegovy.
Nokho, i I-Pharmaceutical Group ye-European Union (PGEU)Inhlangano, emele osokhemisi bomphakathi abangaphezu kuka-400.000, ibheka lezi zixwayiso njengehaba. Unobhala jikelele wayo, u-Ilaria Passarini, ugcizelela ukuthi ayikho inhloso yokuvumela ukukhiqizwa ngobuningi noma ukwakhiwa kwamakhophi emithi emisha, nokuthi amakhemisi omphakathi awaceli izinguquko ukuze andise umthamo wawo wokuhlanganisa.
Khonamanjalo, amazwe angamalungu kanye nePhalamende laseYurophu bayaqhubeka nokuxoxisana ngemininingwane yalokho okubizwa ngokuthi “iphakethe lezemithi,” ngenhloso yokufinyelela isivumelwano sezepolitiki ezinyangeni ezizayo, esimweni esibucayi. ingcindezi yabezindaba mayelana nezingozi ze-Ozempic mbumbulu.
Ukuqhuma kwemakethe eku-inthanethi yemithi yomgunyathi yohlobo lwe-Ozempic
Ngaphandle kwenkulumo-mpikiswano yomthetho, izexwayiso ezivela kuziphathimandla zezempilo zigxile ikakhulukazi ku- indawo yemakethe eku-inthanethi yezidakamizwa zokunciphisa umzimba ze-GLP-1Kokubili i-EMA kanye ne-US Food and Drug Administration (FDA) bathole ukwenyuka okukhulu kwemikhiqizo yomgunyathi ethengiswa njengama-agonists e-GLP-1.
Lokhu kukhwabanisa kubandakanya ukulingisa kwe semaglutide, liraglutide noma tirzepatideLe mikhiqizo, eyethulwa njengezinye "zoqobo" noma "ezijwayelekile" esikhundleni se-Ozempic, Wegovy, noma i-Mounjaro, imakethwa kumawebhusayithi abukeka kahle, izimakethe eziku-inthanethi, izinkundla zokunciphisa umzimba, futhi, ngaphezu kwakho konke, ngezikhangiso eziqondiwe ezinkundleni zokuxhumana.
Iziphathimandla ziqinisekisile ukuthi amaningi alawa makhasi ayasebenza amalogo asemthethweni, izithombe ezishintshiwe, nezincomo ezingamanga ukuboleka ukwethembeka emikhiqizweni. Kwesinye isikhathi, ngisho nezitifiketi ezivela kuma-ejensi alawulayo ase-Europe zenziwe ngomgunyathi ukwenza umsebenzisi akholwe ukuthi umuthi ugunyaziwe.
EYurophu, imithethonqubo icacile: Ukuthengiswa ku-inthanethi kwemithi kadokotela kukhawulelwe kakhuluFuthi emazweni afana neSpain, amakhemisi agunyazwe ngokusemthethweni kuphela angawakhipha, futhi ngaphansi kwezimo ezithile kuphela. Kodwa-ke, amaningi alawa ma-akhawunti aphethwe ngaphandle kwe-EU, okwenza kube nzima ukuvalwa nokushushiswa kwale misebenzi.
Ngaphandle kweYurophu, izinsizakalo zentela e-United States ziye zabika ukuthunyelwa kwamapeni omgunyathi e-Ozempic nawe-Wegovy afihlwe ezintweni zansuku zonkeZithengiswa njengamathoyizi ezingane, okubonisa izinga lokuhleleka kwala manethiwekhi. Umehluko wamanani uma uqhathaniswa nomkhiqizo osemthethweni kanye nesithembiso sokuwuthola "ngaphandle kokulinda nangaphandle kwencwadi kadokotela" yiwona mdwebo omkhulu.
Izingozi zezempilo zangempela: kusukela kumithamo engalungile kuye ezintweni ezinobuthi
Laboratories ezifana U-Eli Lilly, umkhiqizi we-Mounjaro ne-ZepboundSekuphele izinyanga bexwayisa ngokuthi inkinga ayikho nje ezomnotho noma ihlobene nokuncintisana okungafanele. Ingozi enkulu ihlobene nempilo: eziningi zalezi zidakamizwa ezibizwa nge-GLP-1 aziqukethe lokho ezikuthembisayo.
Ngokophenyo lwe-FDA, imikhiqizo yomgunyathi ingakwazi ukuntula isithako esisebenzayoAngase ahlanganise izinto ezihlukene, aqukathe imithamo ephakeme kakhulu noma ephansi kakhulu kunaleyo efanele, noma ahlanganise izinhlanganisela ezinobuthi obuqondile. Ngaphezu kwalokho, avame ukukhiqizwa ezindaweni ezingenazo izilawuli zekhwalithi, ngaphandle kweziqinisekiso zokungabi nanzalo, futhi ngaphandle kokugadwa kwanoma iyiphi inhlangano elawulayo.
Kusukela ngoJulayi 31, 2025, i-FDA yayiqoqe amakhulukhulu emibiko ya izenzakalo ezimbi ezihlobene ne-semaglutide ne-tirzepatide "izinhlanganisela" E-United States, ezinye zalezi zimo zazidinga ukulaliswa esibhedlela. Amacala abhalwe phansi ahlanganisa isiguli esithole ipeni elibhalwe ukuthi Ozempic ngempela eliqukethe i-insulin, nesinye esaqala ukungenwa izifo ezimbi ngemva kokusebenzisa umkhiqizo othengwe ku-inthanethi.
I-EMA yabelana ngalokhu kuhlola futhi igcizelela ukuthi la malungiselelo angekho emthethweni angaholela ukuntuleka komphumela wokwelapha, ukusabela okubi kakhulu, nokusebenzisana okuyingozi neminye imithi. Ngakho-ke, ugcizelela ukuthi lezi zindlela zokwelapha kufanele zisetshenziswe kuphela ngaphansi kokuqondisa kwezokwelapha, nencwadi kadokotela, futhi zithengwe kumakhemisi agunyaziwe.
Esimweni lapho ingcindezi yobuhle kanye nokuphuthuma ukunciphisa umzimba kunqoba ukuhlakanipha, ochwepheshe bayasikhumbuza ukuthi Awukho umuthi ongenabungozifuthi kancane kakhulu uma itholwa ngemigudu egwema noma yiluphi uhlobo lokulawula impilo.
I-Generative AI kanye nokuzenza ongeyena kwezinhlangano zokunakekelwa kwezempilo: ubuso obusha bokukhwabanisa
Ukwenyuka kwemithi yomgunyathi efana ne-Ozempic iqondana nenguquko esheshayo yamaqhinga ezigebengu ze-inthanethi. Uphenyo olwenziwa yinkampani ye-cybersecurity Hlola i-Software Point Technologies Bahlonze isizukulwane esisha sokukhwabanisa kwemithi ehlanganisa ukuthengiswa kwemikhiqizo engekho emthethweni nokusetshenziswa okujulile kobuhlakani bokwenziwa obukhiqizayo.
Esikhundleni sokumane akhiqize kabusha izikhangiso ezimbalwa ezidukisayo, amanye amanethiwekhi obugebengu ayakha wonke "ama-ecosystem" azungeze izidakamizwa ezingamanga ze-GLP-1: amaphrofayela odokotela asunguliwe, imibiko yomtholampilo engelona iqiniso, ukubuyekezwa kwesiguli okwenziwe yi-AI, izitifiketi zokuzijwayeza ezinhle zokukhiqiza, namawebhusayithi okukhokha alingisa amabhizinisi athenjiwe.
Le mikhankaso ikopisha imininingwane eminingi ubunikazi obubonakalayo bezikhungo zezempilo zikazwelonkenjengemibala yebhizinisi, amafonti, imifaniswano, amafulegi, amalogo, nezigxivizo zokulawula. Emazweni aseYurophu, ukulingisa iminyango yezempilo, izinsizakalo zezempilo zikazwelonke, ngisho nezinhlangano zezidakamizwa zihlonziwe, okwenza kube nzima kumsebenzisi ojwayelekile ukuhlukanisa, ekuqaleni nje, ukuthi iwebhusayithi ingokoqobo noma cha.
Iningi lale misebenzi iqala Izithombe "zangaphambi nangemuva" ezidalwe yi-AILe mikhonyovu ikhombisa ukwehla kwesisindo okumangazayo futhi okubonakala kukholakala. Kusukela kulo mthelela wokuqala, isisulu siholelwa endaweni elingisa ulwazi lwezempilo oluphelele: uhlu lwemibuzo yezempilo, izingxoxo "nochwepheshe" abangama-bot empeleni, izincomo eziqondene nomuntu siqu, futhi ekugcineni, inkokhelo yokwelashwa okufanele.
Inzuzo enkulu yabakhwabanisi ukuthi i-AI yokukhiqiza ivumela vumelanisa le mikhankaso ezweni ngalinye ngemizuzu nje embalwaukushintsha amagama odokotela, izimpawu zesikhungo, izilimi, noma imininingwane yamasiko, nokukhipha izinguqulo ezintsha ngokushesha nje lapho ezandulele zitholwa futhi zivalwe ukusebenza.
IYurophu neSpain zibhekene nenselelo yokuqukatha ukukhwabanisa
Esimweni saseYurophu, usongo lwe Imithi mbumbulu efana ne-Ozempic ihlangana nezinye izimpikiswano zempilo: ukushoda, ingcindezi ekunakekelweni okuyisisekelo, ukuntuleka kwezinsiza zokuhlola ku-inthanethi noma umehluko wokulawula phakathi kwaMazwe Angamalungu.
Amazwe afana neSpain asevele anemikhawulo eqinile ekuthengisweni kwezidakamizwa okubhalwe ku-inthanethi, kodwa iziphathimandla ziyakuvuma lokho Izikhangiso zomgunyathi namaphrofayili asebenza ngokuyinhloko ngaphandle kwe-EULokhu kudinga ukubambisana kwamazwe ngamazwe. I-EMA kanye nama-ejensi kazwelonke aqinisa ukugada, aqinise ukulawulwa kwemingcele, futhi axhumane nezikhungo zomthetho ukuze kutholwe ukuthunyelwa okusolisayo.
Ngesikhathi esifanayo, bayakhuthaza Imikhankaso yolwazi eqondiswe kochwepheshe bezempilo kanye nomphakathi, ukuze bakwazi ukubona izimpawu eziyisixwayiso: amanani aphansi kakhulu, izithembiso zemiphumela esheshayo, ithuba lokuthenga ngaphandle kwencwadi kadokotela, noma ukusetshenziswa kwezimpawu zesikhungo ezingahambisani newebhusayithi lapho zivela khona.
Imboni ngokwayo, kusukela emidondoshiya efana neNovo Nordisk kuya ku-Eli Lilly, iyathuthuka amathuluzi okuqinisekisa ubuqiniso yemikhiqizo yayo kanye nokusebenzisana neziphathimandla ezilawulayo kanye nama-ejensi aqinisekisa ukuthotshelwa komthetho ukuze aphishekele kokubili ukwenziwa komgunyathi okubonakalayo kwemithi kanye nokulingisa okudijithali kwemikhiqizo yayo.
Noma kunjalo, isivinini okunikezwayo ngomgunyathi siphindaphindeka ezinkundleni zokuxhumana kanye nezinjini zokusesha sidinga umzamo oqhubekayo wokuhlala unolwazi. Ongoti bayakuvuma lokho Ingcindezi ekwelashweni kokunciphisa i-GLP-1 izoqhubeka okungenani kuze kube ngu-2026inqobo nje uma ukungezwani kokunikezwayo kuqhubeka futhi isidingo siqhubeka nokukhula.
Iziguli zingazivikela kanjani ku-Ozempic mbumbulu?
Ama-ejensi alawulayo kanye nochwepheshe bayakugcizelela ukuthi umugqa wokuqala wokuzivikela yi- ulwazi oluvela esiguliniNakuba imikhonyovu iya ngokuya iba yinkimbinkimbi, kunezinombolo zeziqondiso eziyisisekelo ezinciphisa kakhulu ingcuphe yokuba yisisulu sabo.
Endabeni yeSpain kanye nayo yonke i-EU, isincomo esikhulu thenga kuphela emakhemisi agunyaziweKungakhathaliseki ukuthi mathupha noma, uma kuvunyelwe ngokomthetho, ngezinkundla zabo ezisemthethweni ze-inthanethi, noma iyiphi isayithi enikezela ngemithi kadokotela ngaphandle kwencwadi kadokotela, ngentengo ewuhhafu, noma ngokuthunyelwa okuvela emazweni angaphandle kufanele kubangele izinsolo ngokushesha.
Kubuye kube lula Qaphela izikhangiso ezinkundleni zokuxhumana nasezinkundleni zokuxhumana Bathembisa imiphumela esheshayo, izaphulelo ezinolaka, noma ukutholakala okungenamkhawulo kwemikhiqizo okuthiwa iphelile esitokweni. Eminingi yale milayezo isebenzisa izibali-sikhathi, izexwayiso "zesitoko esilinganiselwe", noma ubufakazi obuyihaba ukuze kuphushelwe izinqumo ezingaphusile.
Esinye isilinganiso esisebenzayo Qinisekisa noma yikuphi ukugunyazwa kwezokwelapha okusolwayo noma uphawu lokulawulaUma iwebhusayithi ithi isekelwa i-EMA, umnyango wezempilo, noma umphakathi wesayensi, kuhle ukuthi uye ngokuqondile kuwebhusayithi esemthethweni yaleyo nhlangano futhi uhlole ukuthi ifakwe ohlwini lwabahlanganyeli noma ibhizinisi eligunyaziwe.
Okokugcina, iziguli ezisebenzisa noma esesizoqala ukwelashwa ngama-agonists e-GLP-1 kufanele Hlala uxoxisana nodokotela wakho nganoma yikuphi okunikezwayo okuku-inthanethi. ukuthi bathole. Uchwepheshe angasiza ekuhlukaniseni imikhiqizo esemthethweni kwezinye izinto ezingelona iqiniso futhi, uma kunezinsolo, eluleka ngokuthi ungayibika kanjani kuziphathimandla ezinekhono.
Ukwanda kwesidingo semithi yokwehlisa isisindo esekwe ku-GLP-1, kuhlanganiswe nezinkinga zokuhlinzekwa kwezidingo kanye nokuphusha okuvela kubuhlakani bokwenziwa, kudale isimo lapho Imithi yomgunyathi yohlobo lwe-Ozempic isiphenduke ibhizinisi elinenzuzo enkulu yobugebengu obuhleliwe.Phakathi kwamagebe okulawula okuxoxwa ngawo eBrussels, ukukhuphuka kwemakethe ye-inthanethi, kanye nemikhankaso eyinkimbinkimbi yokuzenza izinhlangano zezempilo, indima yeziphathimandla, izinkampani zemithi, kanye neziguli ngokwazo zizoba yisihluthulelo sokuvimbela ukufunwa kokulungiswa okusheshayo kokukhuluphala ekugcineni engozini enkulu yezempilo.